NASDAQ:ACHV Achieve Life Sciences (ACHV) Stock Price, News & Analysis $4.92 +0.04 (+0.82%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$4.80▼$5.0050-Day Range$4.51▼$5.5052-Week Range$3.03▼$5.98Volume62,321 shsAverage Volume155,873 shsMarket Capitalization$169.12 millionP/E RatioN/ADividend YieldN/APrice Target$14.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Achieve Life Sciences alerts: Email Address Achieve Life Sciences MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside184.3% Upside$14.00 Price TargetShort InterestBearish7.02% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.06Based on 5 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.04) to ($0.99) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.89 out of 5 starsMedical Sector841st out of 936 stocksDiagnostic Substances Industry11th out of 15 stocks 3.5 Analyst's Opinion Consensus RatingAchieve Life Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageAchieve Life Sciences has only been the subject of 1 research reports in the past 90 days.Read more about Achieve Life Sciences' stock forecast and price target. Previous Next 0.0 Short Interest Percentage of Shares Shorted7.02% of the outstanding shares of Achieve Life Sciences have been sold short.Short Interest Ratio / Days to CoverAchieve Life Sciences has a short interest ratio ("days to cover") of 10.3, which indicates bearish sentiment.Change versus previous monthShort interest in Achieve Life Sciences has recently increased by 58.55%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAchieve Life Sciences does not currently pay a dividend.Dividend GrowthAchieve Life Sciences does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ACHV. Previous Next 2.3 News and Social Media Coverage News SentimentAchieve Life Sciences has a news sentiment score of 0.06. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Achieve Life Sciences this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for ACHV on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat Follows4 people have added Achieve Life Sciences to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Achieve Life Sciences insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.00% of the stock of Achieve Life Sciences is held by insiders.Percentage Held by InstitutionsOnly 33.52% of the stock of Achieve Life Sciences is held by institutions.Read more about Achieve Life Sciences' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Achieve Life Sciences are expected to grow in the coming year, from ($1.04) to ($0.99) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Achieve Life Sciences is -3.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Achieve Life Sciences is -3.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Achieve Life Sciences' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyObama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.” Please, watch this now before it’s too late. About Achieve Life Sciences Stock (NASDAQ:ACHV)Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.Read More ACHV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ACHV Stock News HeadlinesJuly 25 at 8:00 AM | globenewswire.comAchieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024July 24 at 6:38 PM | msn.comIsrael-Hamas War Latest: Netanyahu Addresses Congress and Vows to Achieve 'Total Victory'July 26, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.July 23 at 4:16 AM | americanbankingnews.comAchieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above Two Hundred Day Moving Average of $4.65July 9, 2024 | globenewswire.comAchieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024May 29, 2024 | finance.yahoo.comAchieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-CigarettesMay 25, 2024 | finance.yahoo.comAchieve Life Sciences, Inc. (ACHV)May 17, 2024 | globenewswire.comAchieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual MeetingJuly 26, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.May 13, 2024 | markets.businessinsider.comBuy Rating Affirmed for Achieve Life Sciences Amid Positive Drug Development Progress and Strong Financial PositionMay 11, 2024 | markets.businessinsider.comBuy Rating Affirmed for Achieve Life Sciences on Strong Clinical Progress and Solid Financial FootingMay 10, 2024 | finance.yahoo.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2024 Earnings Call TranscriptMay 10, 2024 | finance.yahoo.comAchieve Life Sciences Inc (ACHV) Reports Q1 2024 Financial ResultsMay 9, 2024 | globenewswire.comAchieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate UpdateMay 9, 2024 | usnews.comIsraeli Defence Minister Tells 'Friends and Enemies' Israel Will Achieve War AimsMay 6, 2024 | globenewswire.comAchieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal MedicineApril 28, 2024 | latimes.comWomen Are on Track to Achieve Parity in Gender Representation Among Corporate Leadership Roles as Soon as 2030April 26, 2024 | msn.comAchieve Life Sciences files to sell 13.09M shares of common stock for holdersSee More Headlines Receive ACHV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Achieve Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today7/26/2024Next Earnings (Confirmed)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryBiotechnology Current SymbolNASDAQ:ACHV CUSIP68230A10 CIK949858 Webachievelifesciences.com Phone(604) 210-2217Fax425-686-1600Employees22Year FoundedN/APrice Target and Rating Average Stock Price Target$14.00 High Stock Price Target$20.00 Low Stock Price Target$11.00 Potential Upside/Downside+184.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($1.29) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,820,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-176.97% Return on Assets-76.60% Debt Debt-to-Equity RatioN/A Current Ratio3.29 Quick Ratio3.29 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-70.36Miscellaneous Outstanding Shares34,340,000Free Float33,654,000Market Cap$169.12 million OptionableOptionable Beta1.54 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Key ExecutivesDr. Richard A. B. Stewart (Age 65)Executive Chairman Comp: $663.75kMr. John A. Bencich M.B.A. (Age 47)CEO & Director Comp: $781.75kDr. Cindy Jacobs M.D. (Age 66)Ph.D., President, Chief Medical Officer & Director Comp: $652.74kMr. Jerry Wan (Age 42)Principal Accounting Officer Dr. Anthony Clarke Ph.D. (Age 68)Chief Scientific Officer Comp: $546kMs. Jaime XinosExecutive Vice President of CommercialMore ExecutivesKey CompetitorsEmergent BioSolutionsNYSE:EBSLexicon PharmaceuticalsNASDAQ:LXRXVanda PharmaceuticalsNASDAQ:VNDAXOMANASDAQ:XOMACodexisNASDAQ:CDXSView All CompetitorsInstitutional OwnershipBank of New York Mellon CorpBought 102,555 shares on 7/26/2024Ownership: 0.299%Virtu Financial LLCBought 12,930 shares on 5/20/2024Ownership: 0.038%Propel Bio Management LLCBought 2,453,092 shares on 5/14/2024Ownership: 7.144%Vanguard Group Inc.Bought 342,731 shares on 5/10/2024Ownership: 2.769%CVI Holdings LLCBought 567,192 shares on 5/7/2024Ownership: 1.656%View All Institutional Transactions ACHV Stock Analysis - Frequently Asked Questions How have ACHV shares performed this year? Achieve Life Sciences' stock was trading at $4.12 at the start of the year. Since then, ACHV stock has increased by 19.5% and is now trading at $4.9250. View the best growth stocks for 2024 here. How were Achieve Life Sciences' earnings last quarter? Achieve Life Sciences, Inc. (NASDAQ:ACHV) released its quarterly earnings data on Thursday, May, 9th. The biopharmaceutical company reported ($0.26) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by $0.02. When did Achieve Life Sciences' stock split? Achieve Life Sciences's stock reverse split on Friday, July 31st 2020. The 1-20 reverse split was announced on Thursday, July 30th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, July 30th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Achieve Life Sciences' major shareholders? Achieve Life Sciences' top institutional investors include Bank of New York Mellon Corp (0.30%) and Concourse Financial Group Securities Inc.. View institutional ownership trends. How do I buy shares of Achieve Life Sciences? Shares of ACHV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Achieve Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Achieve Life Sciences investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Bionano Genomics (BNGO), Novan (NOVN), Aeterna Zentaris (AEZS) and Zosano Pharma (ZSAN). This page (NASDAQ:ACHV) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achieve Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Achieve Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
